📣 VC round data is live. Check it out!

Vivos Valuation Multiples

Discover revenue and EBITDA valuation multiples for Vivos and similar public comparables like Implanet, NeuroOne Medical, Trajan Group Holdings, Acarix and more.

Vivos Overview

About Vivos

Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. IsoPet is another product of the company used for the treatment of solid tumors in animals. The company derives revenue through sales of its products.


Founded

1994

HQ

United States

Employees

1

Financials (FY)

Revenue: -
Net Income: -

EV

$30M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Vivos Stock Performance

Vivos has current market cap of $32M, and enterprise value of $30M.

Market Cap Evolution


Vivos' stock price is $0.07.

Vivos share price decreased by 5.3% in the last 30 days, and by 48.9% in the last year.

See more trading valuation data for Vivos
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$30M$32M0.0%-5.3%-22.7%-48.9%-

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Vivos Valuation Multiples

Vivos Financial Valuation Multiples

As of May 27, 2026, Vivos has market cap of $32M and EV of $30M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Vivos Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Vivos Competitors

Vivos competitors include Implanet, NeuroOne Medical, Trajan Group Holdings, Acarix, Bioretec, Carclo, Nortech Systems, CytoSorbents, Spirit Scientific Co and Polyrizon.

Most Vivos public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Implanet2.4x-(8.1x)-
NeuroOne Medical3.2x2.9x(9.7x)-
Trajan Group Holdings0.5x0.5x6.4x5.8x
Acarix36.0x22.6x(6.2x)(7.3x)
Bioretec7.1x5.9x(3.0x)(3.2x)
Carclo0.4x0.4x3.0x2.7x
Nortech Systems0.4x-22.3x-
CytoSorbents1.4x1.4x(12.3x)-

This data is available for Pro users. Sign up to see all Vivos competitors and their valuation data.

Start Free Trial

Vivos M&A Activity

Vivos has acquired 1 company to date.

Last acquisition by Vivos was on July 15th 2025. Vivos acquired Nice-Pak Products for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Vivos

Nice-Pak Products
Description
Nice-Pak Products is a New Hyde Park-headquartered manufacturer of wet wipes, including sanitizing, baby, flushable, and surface disinfectant varieties produced in facilities across the United States, United Kingdom, and Mexico. Founded in 1960, it supplies private-label products to retailers like Walmart and Procter & Gamble, with production capacity exceeding billions of wipes annually using biodegradable materials.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date15 Jul 2025
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Vivos acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Vivos

When was Vivos founded?Vivos was founded in 1994.
Where is Vivos headquartered?Vivos is headquartered in United States.
How many employees does Vivos have?As of today, Vivos has over 1 employees.
Is Vivos publicly listed?Yes, Vivos is a public company listed on OTC Pink Sheets.
What is the stock symbol of Vivos?Vivos trades under RDGL ticker.
Who are competitors of Vivos?Vivos main competitors include Implanet, NeuroOne Medical, Trajan Group Holdings, Acarix, Bioretec, Carclo, Nortech Systems, CytoSorbents, Spirit Scientific Co, Polyrizon.
What is the current market cap of Vivos?Vivos' current market cap is $32M.
Is Vivos profitable?No, Vivos is not profitable.
How many companies Vivos has acquired to date?As of May 2026, Vivos has acquired 1 company.
What was the largest acquisition by Vivos?None of the M&A deals Vivos has completed have disclosed valuations.
In how many companies Vivos has invested to date?Vivos hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Vivos

Lists including Vivos

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial